As with many types of cancer, early detection of lung cancer is critical for improving health outcomes, and advances in robotic technology have become essential tools in early screening and ...
†PLCO and LFL (p <.05). ††LF and LFL (p <.05). This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text component.
Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study Data ...
BioMark Diagnostics ( ($TSE:BUX) ) has provided an announcement. BioMark Diagnostics Inc. and its research partners have been honored with the ...
Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...
Proposed collaboration aims to integrate cutting-edge AI and genomic insights to advance guideline-directed medical therapy SAN FRANCISCO--(BUSINESS WIRE)-- Viz.ai, the leader in AI-powered disease ...
Model and clinical segmentation examples. (A) 71-year-old female with non-small cell lung cancer (NSCLC) from the internal test set. (B) 87-year-old male with NSCLC from the external test set. Both ...
Detailed price information for Biomark Diagnostics Inc (BUX-CN) from The Globe and Mail including charting and trades.
For decades, lung cancer has been associated with stigma, anxiety, and loss. Advances in screening, therapeutics, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback